294 results · Page 1 of 12

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Clinical Study of Three-dimensional Lattice Radiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Advanced Solid TumorsAdvanced Malignant Solid TumorRecruitingPhase 22026-10-08NCT07865793
SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLCBrain Metastases, Neoplasms by Site, Thoracic Neoplasms, brain disorder, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, central nervous system disorder, lung disorder, lung neoplasm, neoplasm, nervous system disorder, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingPhase 32026-10-08NCT06457906
The QL1706 Combined With Chemotherapy and Either Cetuximab or Bevacizumab in Potentially Resectable Colorectal Cancer Patients With Liver MetastasesColorectal Cancer Metastatic to LiverNot yet recruitingPhase 1 / Phase 22026-10-07NCT07863869
Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive LymphomaAggressive LymphomaRecruitingNot applicable2026-10-07NCT07657494
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell CarcinomaConcurrent Chemoradiotherapy; Immunonutrition; Locally Advanced Esophageal Squamous Cell Carcinoma; Radiotherapy; SintilimabRecruitingPhase 22026-10-07NCT06342167
Phase I Study of In Vivo CAR-Tumor Technology for the Treatment of Advanced Malignant TumorsAdvanced Solid TumorNot yet recruitingPhase 12026-10-05NCT07859462
Radiotherapy Target Volume Delineation in Locally Advanced Esophageal Cancer in the Immunotherapy EraDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasmRecruitingNot stated2026-10-05NCT07858630
Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI ResistanceEGFR-TKI-resistant Non-Small Cell Lung CancerNot yet recruitingPhase 12026-09-25NCT07842887
Rimegepant Plus Toripalimab in Advanced Urothelial Carcinoma After Failure of Standard TherapyAdvanced Urothelial CarcinomaRecruitingPhase 12026-09-22NCT07835035
Efficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junction CancerLocally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaActive, not recruitingNot stated2026-09-22NCT07429318
Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell CarcinomaDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, cervical squamous cell carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell lung carcinoma, squamous cell neoplasmActive, not recruitingNot stated2026-09-18NCT07147361
Video-Assisted Thoracoscopic Surgery Combined With Radiofrequency Ablation Versus VATS Alone for Multiple Primary Lung CancerMultiple Primary Lung CancersNot yet recruitingNot applicable2026-09-15NCT07819669
Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasmRecruitingNot applicable2026-09-15NCT06146946
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular CarcinomaAdvanced HBV-Related Hepatocellular CarcinomaRecruitingPhase 12026-08-31NCT07557251
ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLCNeoplasm, Residual, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasmActive, not recruitingNot stated2026-08-31NCT05198154
YSCH-01 Via Nebulization in Pulmonary Metastasis of Advanced Solid Tumors and Non-small Cell Lung Cancer (NSCLC)DNA Virus Infections, Infections, Neoplasms by Site, Thoracic Neoplasms, adenoviridae infectious disease, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, viral infectious diseaseRecruitingEarly phase 12026-08-28NCT07793500
A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory LymphomaHemic and Lymphatic Diseases, Lymphoma, Extranodal NK-T-Cell, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmNot yet recruitingPhase 22026-08-28NCT07791615
Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck CancerHead and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinomaActive, not recruitingPhase 22026-08-28NCT07791602
Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC StudyMeta-Learning; Multimodal; Predictive Models; Triple -Negative Breast CancertripleRecruitingNot stated2026-08-19NCT07773818
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast CancerDisease Attributes, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasmRecruitingNot stated2026-08-18NCT06993506
Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer(UPGRADE-TNBC)Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinomaEnrolling by invitationPhase 2 / Phase 32026-08-18NCT06910072
COLORS-Validate Study of Decision-Support Software for Surgical Sequencing in Colorectal Liver MetastasesColorectal Liver MetastasesNot yet recruitingNot stated2026-08-12NCT07760558
SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular CarcinomaDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmNot yet recruitingPhase 22026-08-06NCT07749859
Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical CancerCancer of the Uterine Cervix, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorderRecruitingNot applicable2026-08-05NCT07684508
MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell CarcinomaHead and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinomaNot yet recruitingPhase 22026-08-05NCT07677475